knowledge -WSS

knowledge

author：focus 2025-09-27 23:32:37 - browse：3783

The Blue Shield of California headquarters building is seen in San Francisco – health care policy from STAT — Eric Risberg/AP

Two dominant Blue Cross Blue Shield companies in California intentionally underreported premiums of certain health plans so they could avoid paying Affordable Care Act taxes, according to new federal whistleblower complaints.

These claims renew concerns about whether health insurance companies have skirted the tax code and to what extent tax fraud could exist in the industry.

Blue Shield of California evaded $111 million in taxes between 2016 and 2020, according to a complaint that was filed with the Internal Revenue Service on June 27. Elevance Health, the parent company of Anthem Blue Cross in California, evaded $60 million in taxes during the same time period, according to a separate complaint filed with the IRS.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： In Spain, a hospital brews its own CAR

leisure time

WSS

SAMSHA loosens regulations on methadone treatment centers

Can sheer will power keep patients alive in their dying hours?

The real point of Kenneth Smith’s execution by nitrogen gas

Commercial surrogacy can be ethical, despite pope’s claims

Time to name cancers by genetics, not organ of origin, expert says

Biden administration opens offers in Medicare drug price negotiations

leisure time

knowledge

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: The latest on Moderna, Apellis, and Merck

DIEP, the 'gold standard' of breast reconstruction, is under threat

A $475,000 price tag for a new cancer drug: crazy or meh?

Novavax promises a turnaround & Lilly roils the obesity market

Editas, Vertex strike deal on CRISPR

Heart attack and stroke risk calculators need revising

How to keep neuroscience’s past racism from being its future

Medicare proposal to cover medical devices draws a mixed reaction

Do digital therapeutics have a future in medicine?

knowledge

Medicare drug price negotiation’s day in court

Why health care costs have stayed mostly flat since 2010

Editas, Vertex strike deal on CRISPR

Biden administration opens offers in Medicare drug price negotiations

Time to name cancers by genetics, not organ of origin, expert says

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

hotspot

leisure time

hotspot

explore